← All patents

US12396988B2

Methods of using muscarinic antagonists in the treatment of depression

University of Texas System

Abstract

Muscarinic antagonist are provided that are used in the treatment of depression in a subject, such as humans. The muscarinic antagonist of the invention can relieve depression without effecting cognitive functions in the treated subject.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Andrew Coop
Priority date
April 04, 2019
Filing date
April 06, 2020
Grant date
August 26, 2025
Publication date
August 26, 2025
Language
en
Metadata fetched
August 29, 2026 00:35